Digital Polymerase Chain Reaction (dPCR) is an advancement of traditional polymerase chain reaction (PCR). The traditional PCR with its limited precision and accuracy often fail to amplify small samples of nucleic acid to a detectable level. This has evoked a need of better techniques to assess the minute quantities of DNA or RNA. dPCR is more sensitive and reliable technique with improved ability to quantify the absolute amount of nucleic acid. It divides the sample into large number of fragments, each containing either one or no template nucleic acid sequence. After DNA amplification, scoring is done with the help of fluorescence, counting the score as positive for the fraction containing template sequence and negative for the sample without the template sequence. The major factors driving the global digital polymerase chain reaction market are increasing demand for innovative diagnostic techniques, increasing disease awareness, need for early diagnosis of viral, infectious and genetic disease, and increasing number of diagnostic centers across the globe. However, high cost of dPCR testing and limited expertise and accessibility, especially in the developing countries are likely to restrict the market growth.
The global digital polymerase chain reaction (dPCR) market is segmented on the basis of technology, type, application, end user and geography. According to technology, the market is segmented into Droplet Digital PCR (ddPCR) and BEAMing Digital PCR. On the basis of type, the market is segmented into Digital PCR equipment and consumables. Based on application, it is segmented into clinical diagnostics, research and others. On the basis of end user, the market is segmented into pharmaceuticals and biotechnology industries, hospitals and clinical diagnostic centers, and university and research organizations. Geographically, the market is segmented across four regions viz., North America, Europe, Asia-Pacific, and LAMEA.
New product launch is among the few strategies adopted by key industry players. Recently, JN Medsys, in collaboration with Institute of Bioengineering and Nanotechnology (IBN) introduced Clarity Digital PCR system for the detection of mutations in cancer and fetal abnormalities. It is a technologically advanced product, provided with reduced preparation time and simplified workflow. The companies profiled in this report include Thermo Fisher Scientific Inc., RainDance Technologies Inc., Bio-Rad Laboratories Inc., Fluidigm Corporation, Formulatrix Inc., Promega Corporation, JN Medsys Pte Ltd. and Stilla Technologies.
KEY MARKET BENEFITS
Comprehensive analysis of factors that drive and restrict the growth of the global digital polymerase chain reaction (dPCR) market is provided
The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
An in-depth analysis of key segments of the market demonstrate the types of dPCR equipment along with the technologies, applications and end-users in the dPCR market
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
Region-wise digital polymerase chain reaction market conditions are comprehensively analyzed in the report
KEY MARKET SEGMENTS:
The global Digital Polymerase Chain Reaction (dPCR) market is segmented below:
- Global Digital Polymerase Chain Reaction (dPCR) Market - By Technology
- Droplet Digital PCR (ddPCR)
- BEAMing Digital PCR
Global Digital Polymerase Chain Reaction (dPCR) Market - By Type
- Digital PCR equipment
- Consumables and reagents
Global Digital Polymerase Chain Reaction (dPCR) Market - By Application
- Research
- Clinical diagnostics
- Others
Global Digital Polymerase Chain Reaction (dPCR) Market - By End User
- Pharmaceuticals and biotechnology industries
- Hospitals and clinical diagnostic centers
- University and research organizations
Global Digital Polymerase Chain Reaction (dPCR) Market - By Geography
- North America
- Europe
- Asia-Pacific
- LAMEA
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
